BJ
BIENAIME JEAN JACQUES Other
US US · SEC (Form 4)
Browse the complete record of transactions filed by BIENAIME JEAN JACQUES. Insider active across 2 companies, notably Biomarin Pharmaceutical INC. In total, 26 filings have been logged. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations 26 total
02,144 shares 0
Common Stock
SEC:0001209191-22-037797:0 · 15 Jun 2022
€20,259 341 shares @ €59.4115 0.0002% mcap 0.7% of flow
Common Stock
SEC:0001567619-22-009865:0 · 29 Apr 2022
€713,238 20,000 shares @ €35.6619 0.0062% mcap 24.6% of flow
Common Stock
SEC:0001567619-22-009319:0 · 28 Apr 2022
€694,875 20,000 shares @ €34.7438 0.0061% mcap 24.0% of flow
Common Stock
SEC:0001567619-22-008742:0 · 18 Apr 2022
€346,179 10,000 shares @ €34.6179 0.0030% mcap 11.9% of flow
Common Stock
SEC:0001567619-22-008635:0 · 14 Apr 2022
040,280 shares 0
Common Stock
SEC:0001567619-22-007179:0 · 15 Mar 2022
€507,413 15,000 shares @ €33.8275 0.0044% mcap 17.5% of flow
Common Stock
SEC:0001567619-22-006946:0 · 10 Mar 2022
034,780 shares 0
Common Stock
SEC:0001567619-22-006720:0 · 8 Mar 2022
€7,912 100 shares @ €79.1172 2.6% of flow
Common Stock
SEC:0001567619-22-001225 · 21 Dec 2021
€7,912 100 shares @ €79.1172 0.0001% mcap 0.3% of flow
Common Stock
SEC:0001567619-22-001225:0 · 21 Dec 2021
0700 shares 0
Common Stock
SEC:0001567619-21-022297 · 10 Dec 2021
0700 shares 0
Common Stock
SEC:0001567619-21-022297:0 · 10 Dec 2021
€3,330 50 shares @ €66.6079 1.1% of flow
Common Stock
SEC:0001567619-21-021536 · 9 Sept 2021
€3,330 50 shares @ €66.6079 0.0000% mcap 0.1% of flow
Common Stock
SEC:0001567619-21-021536:0 · 9 Sept 2021
€32,141 1,000 shares @ €32.1407 10.4% of flow
Common Stock
SEC:0001567619-21-018613 · 20 Oct 2021
€32,141 1,000 shares @ €32.1407 0.0003% mcap 1.1% of flow
Common Stock
SEC:0001567619-21-018613:0 · 20 Oct 2021
€31,446 1,000 shares @ €31.4458 10.2% of flow
Common Stock
SEC:0001567619-21-012534 · 21 Jun 2021
€31,446 1,000 shares @ €31.4458 0.0003% mcap 1.1% of flow
Common Stock
SEC:0001567619-21-012534:0 · 21 Jun 2021
01,923 shares 0
Common Stock
SEC:0001209191-21-036399 · 26 May 2021
01,923 shares 0
Common Stock
SEC:0001209191-21-036399:0 · 26 May 2021
€185,743 8,513 shares @ €21.8188 60.1% of flow
Common Stock
SEC:0001567619-21-009745 · 10 May 2021
€185,743 8,513 shares @ €21.8188 0.0016% mcap 6.4% of flow
Common Stock
SEC:0001567619-21-009745:0 · 10 May 2021
€17,548 341 shares @ €51.4608 5.7% of flow
Common Stock
SEC:0001567619-21-009481 · 30 Apr 2021
€17,548 341 shares @ €51.4608 0.0002% mcap 0.6% of flow
Common Stock
SEC:0001567619-21-009481:0 · 30 Apr 2021
€30,890 1,000 shares @ €30.8895 10.0% of flow
Common Stock
SEC:0001567619-21-008885 · 30 Apr 2021
25 of 26 declarations
Load more (1 remaining) About BIENAIME JEAN JACQUES Jean Jacques Bienaime is an executive at BioMarin Pharmaceutical Inc.